Cheryl A. Graves

Cheryl A. Graves has a strong background in clinical operations and development. Cheryl A. is currently the Head of Clinical Operations at Alto Neuroscience since January 2024. Prior to that, they worked as the Director of Clinical Development Operations at Reunion Neuroscience from March 2023 to January 2024. From October 2021 to February 2023, Cheryl was the Director of Clinical Operations at Clexio Biosciences. Before that, they held two positions at Axsome Therapeutics, Inc: Director of Clinical Operations from March 2020 to September 2021, and Associate Director of Clinical Operations from September 2018 to March 2020. Cheryl also worked as an Associate Director of Clinical Operations at Edge Therapeutics, Inc. from January 2015 to August 2018. Cheryl A. began their career as an Expert Clinical Manager at Novartis from March 2013 to January 2015, and before that, they worked as a Clinical Scientist at Forest Research Inc. from March 2002 to March 2013.

Cheryl A. Graves completed their Master of Science in Organizational Leadership (MSOL) at Quinnipiac University from 2017 to 2018. Prior to that, they obtained their Bachelor of Science (B.S.) in Psychology from the University of Phoenix, graduating between 2007 and 2011.